SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for RXST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 117.31M
March 31, 2026 115.87M
December 31, 2025 112.65M
September 30, 2025 113.17M
June 30, 2025 111.43M
March 31, 2025 106.74M
December 31, 2024 101.43M
September 30, 2024 94.39M
June 30, 2024 87.92M
March 31, 2024 81.87M
December 31, 2023 74.80M
September 30, 2023 69.37M
Date Value
June 30, 2023 65.15M
March 31, 2023 61.30M
December 31, 2022 58.66M
September 30, 2022 54.55M
June 30, 2022 48.70M
March 31, 2022 40.82M
December 31, 2021 32.81M
September 30, 2021 21.19M
June 30, 2021 15.81M
March 31, 2021 9.309M
June 30, 2020 3.698M
March 31, 2020 3.698M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Precision Optics Corp., Inc. 7.708M
Alcon AG 3.612B
UFP Technologies, Inc. 83.81M
TransMedics Group, Inc. 218.27M
Hyperfine, Inc. 26.53M